Spero Therapeutics Inc (SPRO)
0.9367
+0.01
(+1.51%)
USD |
NASDAQ |
Dec 24, 13:00
0.9367
0.00 (0.00%)
After-Hours: 13:15
Spero Therapeutics Free Cash Flow: -17.54M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CytomX Therapeutics Inc | -88.78M |
| Castle Biosciences Inc | 34.54M |
| Arbutus Biopharma Corp | -71.92M |
| PTC Therapeutics Inc | -274.19M |
| Equillium Inc | -21.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 12.76M |
| Free Cash Flow Per Share (Quarterly) | 0.2358 |
| Free Cash Flow to Equity (Quarterly) | 12.76M |
| Free Cash Flow to Firm (Quarterly) | 12.76M |
| Free Cash Flow Yield | -34.71% |